Exits

The Connecticut-based healthcare investor has closed its sale of EAS to pharma giant Abbott Laboratories for $320m.

Graphite Capital has made 5x its money on the £63m refinancing of Wagamama in a deal funded by Hutton Collins and Royal Bank of Scotland.

The New York- and Cleveland, Ohio-based middle-market specialist beat its original fundraising target set in June 2003, raising almost double the capital of its previous fund.

The UK-based mid-market buyout firm has secured E50m of commitments for its second fund including a E10m investment from Inflexion Plc.

Edinburgh-based Albany Ventures has received commitments from Scottish Widows, BoS, Alliance Trusts and Martin Currie en route to a £40m final closing.

The £84m deal makes it 47 realisations in 18 months for the firm, and over $1bn returned to investors.